CORRECTION: ProMIS Neurosciences Q4 EPS $(3.11) Misses $(0.21) Estimate

ProMIS Neurosciences (NASDAQ: PMN) reported a Q4 loss of $(3.11) per share, significantly missing the analyst consensus estimate of $(0.21) by 1380.95%. This represents a 522% increase in losses compared to $(0.50) per share from the same period last year.